Lasofoxifene Tartrate — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-12-31 in 3mo
ESTIMATED |
READOUT
Proof of Concept Study of Vaginal AZU-101 in Vulvovaginal Atrophy in Postmenopau
Phase 2 · Vulvo Vaginal Atrophy (VVA) |
Azure Biotech Inc. | Lasofoxifene Tartrate |
ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
|